CHINA PHARMA<01093> - Results Announcement (Summary)
China Pharmaceutical Group Limited announced on 22/3/2004:
(stock code: 01093 )
Year end date: 31/12/2003
Currency: HKD
Auditors' Report: Unqualified
(Audited )
(Audited ) Last
Current Corresponding
Period Period
from 1/1/2003 from 1/1/2002
to 31/12/2003 to 31/12/2002
Note ('000 ) ('000 )
Turnover : 2,478,426 1,625,130
Profit/(Loss) from Operations : 618,289 297,891
Finance cost : (25,361) (26,682)
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : 7,610 7,916
Profit/(Loss) after Tax & MI : 504,169 228,142
% Change over Last Period : +121 %
EPS/(LPS)-Basic (in dollars) : 0.3327 0.1662
-Diluted (in dollars) : 0.3283 0.1635
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : 504,169 228,142
Final Dividend : HK 7.0 cents HK 6.0 cents
per Share
(Specify if with other : N/A N/A
options)
B/C Dates for
Final Dividend : 10/5/2004 to 14/5/2004 bdi.
Payable Date : 28/5/2004
B/C Dates for Annual
General Meeting : 10/5/2004 to 14/5/2004 bdi.
Other Distribution for : N/A
Current Period
B/C Dates for Other
Distribution : N/A
Remarks:
1. Profit from operations
2003 2002
HK$'000 HK$'000
Profit from operations has been arrived
at after charging (crediting):
Amortisation of intangible assets 13,770 14,303
Amortisation of goodwill 3,168 1,546
Depreciation of property, plant and equipment 129,024 103,818
Impairment of intangible assets 10,878 -
Bank interest income (1,589) (1,737)
======== ========
2. Earnings per share
The calculation of the basic and diluted earnings per share is based on
the following data:
2003 2002
Profit attributable to shareholders HK$504,169,000 HK$228,142,000
================= ==============
Weighted average number of ordinary
shares for the purposes of basic
earnings per share 1,515,192,387 1,373,033,290
Effect of dilutive potential ordinary
shares in respect of share options 20,501,401 22,612,855
----------------- -------------
Weighted average number of ordinary
shares for the purposes of diluted
earnings per share 1,535,693,788 1,395,646,145
================= =============
|
